We are live on ! Find out more
RIG

Roosevelt Investment Group Portfolio holdings

AUM $1.39B
1-Year Est. Return 5.42%
This Fund
S&P 500
This Quarter Est. Return
+15.34%
1 Year Est. Return
-5.42%
3 Year Est. Return
+57.62%
5 Year Est. Return
+104.74%
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$176M
Cap. Flow
+$10.4M
Cap. Flow %
0.74%
Top 10 Hldgs %
33.19%
Holding
228
New
14
Increased
82
Reduced
71
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 16.57%
2 Consumer Discretionary 12.15%
3 Financials 11.95%
4 Healthcare 9.58%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
51
Eli Lilly
LLY
$1.06T
$7.06M 0.5%
41,793
+315
+0.8% +$47K
OLED icon
52
Universal Display
OLED
$4.19B
$5.84M 0.41%
25,436
-236
-0.9% -$50.4K
XIFR
53
XPLR Infrastructure LP
XIFR
$1.08B
$5.61M 0.4%
83,597
+24
+0% +$1.55K
VEA icon
54
Vanguard FTSE Developed Markets ETF
VEA
$236B
$5.23M 0.37%
110,691
-643
-0.6% -$28.3K
PG icon
55
Procter & Gamble
PG
$339B
$4.71M 0.33%
33,846
+90
+0.3% +$12.6K
IWS icon
56
iShares Russell Mid-Cap Value ETF
IWS
$16B
$4.49M 0.32%
46,291
-256
-0.5% -$23.1K
ABBV icon
57
AbbVie
ABBV
$435B
$3.68M 0.26%
34,316
+36
+0.1% +$3.46K
AJG icon
58
Arthur J. Gallagher & Co
AJG
$63.6B
$3.61M 0.26%
29,183
INTC icon
59
Intel
INTC
$513B
$3.42M 0.24%
68,618
-714
-1% -$34.9K
WY icon
60
Weyerhaeuser
WY
$18.4B
$3.24M 0.23%
96,514
-1,208
-1% -$36.3K
AZN icon
61
AstraZeneca
AZN
$250B
$3.06M 0.22%
30,586
+305
+1% +$32.3K
PFE icon
62
Pfizer
PFE
$153B
$3M 0.21%
81,499
-237,693
-74% -$8.72M
VIG icon
63
Vanguard Dividend Appreciation ETF
VIG
$114B
$2.91M 0.21%
20,627
+245
+1% +$33.2K
SPIB icon
64
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$2.86M 0.2%
76,848
+3,465
+5% +$128K
VOO icon
65
Vanguard S&P 500 ETF
VOO
$1.01T
$2.85M 0.2%
8,298
-3,111
-27% -$1.01M
IBM icon
66
IBM
IBM
$224B
$2.82M 0.2%
23,447
+390
+2% +$45.1K
SPY icon
67
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$2.69M 0.19%
7,182
-144
-2% -$51.1K
ETN icon
68
Eaton
ETN
$174B
$2.6M 0.18%
21,625
EPD icon
69
Enterprise Products Partners
EPD
$81.7B
$2.59M 0.18%
132,330
+57,591
+77% +$1.07M
RTX icon
70
RTX Corp
RTX
$301B
$2.54M 0.18%
35,526
Y
71
DELISTED
Alleghany Corp
Y
$2.48M 0.18%
4,116
+2
+0% +$1.17K
CVS icon
72
CVS Health
CVS
$122B
$2.41M 0.17%
35,243
+18,103
+106% +$1.18M
PCH
73
DELISTED
PotlatchDeltic
PCH
$2.4M 0.17%
48,000
SO icon
74
Southern Company
SO
$107B
$2.34M 0.17%
38,049
+45
+0.1% +$2.71K
GIS icon
75
General Mills
GIS
$19.7B
$2.31M 0.16%
39,329
+44
+0.1% +$2.66K

Similar funds

Roosevelt Investment Group's Q4 2020 Portfolio in Review

As of Q4 2020, Roosevelt Investment Group held 228 positions worth $1.41B, up 14% from $1.23B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Roosevelt Investment Group's Q4 2020 filing shows 14 new, 82 increased, 71 reduced and 6 closed positions. Its largest new stake was Marriott International: 67,830 shares worth $8.95M. The largest sale was Pfizer, an estimated $8.72M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Roosevelt Investment Group's largest Q4 2020 buy was Marriott International: 67,830 shares worth $8.95M.
  • Roosevelt Investment Group added most to Celanese in Q4 2020, an estimated $6.25M increase.
  • Roosevelt Investment Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $8.72M.
  • Roosevelt Investment Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.61M.
  • Roosevelt Investment Group's ten largest holdings make up 33% of its $1.41B portfolio in Q4 2020.
  • Roosevelt Investment Group opened 14 new positions and closed 6 in Q4 2020.
  • Roosevelt Investment Group's portfolio value rose 14% quarter-over-quarter to $1.41B.

Based on Roosevelt Investment Group's 13F filing for Q4 2020, filed 12 Feb 2021.